ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)

SHA:603976 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	645.88	797.8	896.9	793.01	793.62	500.4
Other Revenue	3.33	3.33	3.74	3.19	3.04	1.59
Revenue	649.21	801.12	900.65	796.2	796.66	501.98
Revenue Growth (YoY)	-22.94%	-11.05%	13.12%	-0.06%	58.70%	-3.67%
Cost of Revenue	551.94	653.93	759.02	642.95	598.3	395.23
Gross Profit	97.27	147.2	141.63	153.25	198.36	106.75
Selling, General & Admin	51.37	57.53	57.13	57.46	58.93	45.68
Research & Development	13.81	20.26	23.43	19.11	12.08	8.25
Other Operating Expenses	6.59	0.02	9.32	9.54	9.22	8.16
Operating Expenses	71.02	77.52	90.76	86.73	81.82	62.23
Operating Income	26.25	69.67	50.87	66.52	116.54	44.52
Interest Expense	-20.98	-20.95	-21.26	-19.61	-13.08	-0.29
Interest & Investment Income	8.09	9.8	9.17	8.39	9.12	10.76
Currency Exchange Gain (Loss)	0.07	0.07	-0.25	-0.04	0.73	0.07
Other Non Operating Income (Expenses)	2.85	-0.04	-0.04	-0.06	0.05	-0.21
EBT Excluding Unusual Items	16.27	58.56	38.49	55.2	113.37	54.84
Gain (Loss) on Sale of Investments	0.43	0.47	1.05	-0.94	4.76	-
Gain (Loss) on Sale of Assets	-5.39	-5.3	-0.19	-1.32	-0.53	0
Asset Writedown	0.98	-	-	-	-	-0.7
Legal Settlements	-	-	-	-	-1.87	-
Other Unusual Items	6.53	6.49	5.47	5.61	10.25	7.23
Pretax Income	18.83	60.21	44.83	58.55	125.97	61.38
Income Tax Expense	1.18	6.96	4.56	-6.22	19.37	8.33
Net Income	17.65	53.25	40.27	64.77	106.6	53.05
Net Income to Common	17.65	53.25	40.27	64.77	106.6	53.05
Net Income Growth	-68.76%	32.24%	-37.83%	-39.24%	100.95%	-13.11%
Shares Outstanding (Basic)	149	152	149	151	150	152
Shares Outstanding (Diluted)	149	152	149	151	150	152
Shares Change (YoY)	-2.07%	2.01%	-0.99%	0.32%	-0.94%	-0.70%
EPS (Basic)	0.12	0.35	0.27	0.43	0.71	0.35
EPS (Diluted)	0.12	0.35	0.27	0.43	0.71	0.35
EPS Growth	-68.10%	29.63%	-37.21%	-39.44%	102.86%	-12.50%
Free Cash Flow	93.85	40.2	104.22	-237.66	-32.58	-54.1
Free Cash Flow Per Share	0.63	0.26	0.70	-1.58	-0.22	-0.36
Dividend Per Share	0.246	0.346	0.200	0.060	0.308	0.036
Dividend Growth	-18.00%	73.00%	233.33%	-80.52%	755.56%	-88.89%
Gross Margin	14.98%	18.37%	15.72%	19.25%	24.90%	21.27%
Operating Margin	4.04%	8.70%	5.65%	8.35%	14.63%	8.87%
Profit Margin	2.72%	6.65%	4.47%	8.13%	13.38%	10.57%
Free Cash Flow Margin	14.46%	5.02%	11.57%	-29.85%	-4.09%	-10.78%
EBITDA	147.33	184.05	156.3	152.62	182.98	98.01
EBITDA Margin	22.69%	22.97%	17.36%	19.17%	22.97%	19.53%
D&A For EBITDA	121.08	114.37	105.43	86.11	66.45	53.49
EBIT	26.25	69.67	50.87	66.52	116.54	44.52
EBIT Margin	4.04%	8.70%	5.65%	8.35%	14.63%	8.87%
Effective Tax Rate	6.26%	11.56%	10.17%	-	15.38%	13.56%
Revenue as Reported	649.21	801.12	900.65	796.2	796.66	501.98
Advertising Expenses	-	-	-	0.6	2.02	1.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.